Table of Contents
Chemotherapy Research and Practice
Volume 2014 (2014), Article ID 936526, 8 pages
http://dx.doi.org/10.1155/2014/936526
Research Article

Protective Effect of Quercetin on Melphalan-Induced Oxidative Stress and Impaired Renal and Hepatic Functions in Rat

Biochemistry Unit, Department of Chemical Sciences, Ajayi Crowther University, PMB 1066, Oyo, 211213 Oyo State, Nigeria

Received 30 August 2014; Accepted 23 November 2014; Published 11 December 2014

Academic Editor: Paolo Pronzato

Copyright © 2014 Ebenezer Tunde Olayinka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. K. McEvoy, AHFS 2006 Drug Information, American Society of Health-System Pharmacists, Bethesda, Md, USA, 2006.
  2. D. A. Volpe and M. K. Warren, “Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents,” Toxicology in Vitro, vol. 17, no. 3, pp. 271–277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Zhang, Z. Ye, and Y. Lou, “Metabolism of melphalan by rat liver microsomal glutathione S-transferase,” Chemico-Biological Interactions, vol. 152, no. 2-3, pp. 101–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. Devine, R. Sanborn, E. Jessop et al., “Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant,” Bone Marrow Transplantation, vol. 28, no. 6, pp. 557–562, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kresse, Mechanism of liver cell injury by the cytostatic drug melphalan [Dissertation], 2005.
  6. P. D. King and M. C. Perry, “Hepatotoxicity of chemotherapy,” The Oncologist, vol. 6, no. 2, pp. 162–176, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Kresse, M. Latta, G. Künstle et al., “Kupffer cell-expressed membrane-bound TNF mediates melphalan hepatotoxicity via activation of both TNF receptors,” Journal of Immunology, vol. 175, no. 6, pp. 4076–4083, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Sahni, D. Choudhury, and Z. Ahmed, “Chemotherapy-associated renal dysfunction,” Nature Reviews Nephrology, vol. 5, no. 8, pp. 450–462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Leung, J. M. Slezak, E. J. Bergstralh et al., “Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation,” American Journal of Kidney Diseases, vol. 45, no. 1, pp. 102–111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. O. O. Shevchuk, K. A. Posokhova, A. S. Sidorenko et al., “The influence of enterosorption on some haematological and biochemical indices of the normal rats after single injection of melphalan,” Experimental Oncology, vol. 36, no. 2, pp. 94–100, 2014. View at Google Scholar
  11. C. Gorrini, I. S. Harris, and T. W. Mak, “Modulation of oxidative stress as an anticancer strategy,” Nature Reviews Drug Discovery, vol. 12, no. 12, pp. 931–947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Khan, J. J. Ramwani, and P. J. O'Brien, “Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugsn,” Biochemical Pharmacology, vol. 43, no. 9, pp. 1963–1967, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Chandra, A. Samali, and S. Orrenius, “Triggering and modulation of apoptosis by oxidative stress,” Free Radical Biology and Medicine, vol. 29, no. 3-4, pp. 323–333, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. K. A. Conklin, “Dietary polyunsaturated fatty acids: impact on cancer chemotherapy and radiation,” Alternative Medicine Review, vol. 7, no. 1, pp. 4–21, 2002. View at Google Scholar · View at Scopus
  15. J. M. C. Gutteridge, “Lipid peroxidation and antioxidants as biomarkers of tissue damage,” Clinical Chemistry, vol. 41, no. 12, pp. 1819–1828, 1995. View at Google Scholar · View at Scopus
  16. R. K. Murray, D. K. Granner, P. A. Mayer, and V. W. Rodwell, Harpers Biochemistry, 25th edition, 2000.
  17. T. P. A. Devasagayam, J. C. Tilak, K. K. Boloor, K. S. Sane, S. S. Ghaskadbi, and R. D. Lele, “Free radicals and antioxidants in human health: current status and future prospects,” Journal of Association of Physicians of India, vol. 52, pp. 794–804, 2004. View at Google Scholar · View at Scopus
  18. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, “Free radicals, metals and antioxidants in oxidative stress-induced cancer,” Chemico-Biological Interactions, vol. 160, no. 1, pp. 1–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. Rice-Evans, N. J. Miller, and G. Paganga, “Structure-antioxidant activity relationships of flavonoids and phenolic acids,” Free Radical Biology and Medicine, vol. 20, no. 7, pp. 933–956, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Murota and J. Terao, “Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism,” Archives of Biochemistry and Biophysics, vol. 417, no. 1, pp. 12–17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Stephen-Cole, “Quercetin: a review of clinical applications,” Clinical Sciences, vol. 40, pp. 234–238, 1998. View at Google Scholar
  22. H. Liu, L. Zhang, and S. Lu, “Evaluation of antioxidant and immunity activities of quercetin in isoproterenol-treated rats,” Molecules, vol. 17, no. 4, pp. 4281–4291, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Ø. Moskaug, H. Carlsen, M. Myhrstad, and R. Blomhoff, “Molecular imaging of the biological effects of quercetin and quercetin-rich foods,” Mechanisms of Ageing and Development, vol. 125, no. 4, pp. 315–324, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Abdelmoaty, M. A. Ibrahim, N. S. Ahmed, and M. A. Abdelaziz, “Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in rats,” Indian Journal of Clinical Biochemistry, vol. 25, no. 2, pp. 188–192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. A. Choi, J. Y. Kim, J. Y. Lee et al., “Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin,” International Journal of Oncology, vol. 19, no. 4, pp. 837–844, 2001. View at Google Scholar · View at Scopus
  26. C. S. Ong, E. Tran, T. T. T. Nguyen et al., “Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions,” Oncology Reports, vol. 11, no. 3, pp. 727–733, 2004. View at Google Scholar · View at Scopus
  27. A. M. Seufi, S. S. Ibrahim, T. K. Elmaghraby, and E. E. Hafez, “Preventive effect of the flavonoid,quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences,” Journal of Experimental & Clinical Cancer Research, vol. 28, no. 1, article 80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Sak, “Chemotherapy and dietary phytochemical agents,” Chemotherapy Research and Practice, vol. 2012, Article ID 282570, 11 pages, 2012. View at Publisher · View at Google Scholar
  29. E. Atef and A. El-Baky, “Quercetin protective action on oxidative stress, sorbitol, insulin risistance and cells function in expermintal diabetic rats,” International Journal of Pharmaceutical Studies and Research, vol. 2, no. 2, pp. 11–18, 2011. View at Google Scholar
  30. S. K. Mishra, P. Singh, and S. K. Rath, “Protective effect of quercetin on chloroquine-induced oxidative stress and hepatotoxicity in mice,” Malaria Research and Treatment, vol. 2013, Article ID 141734, 10 pages, 2013. View at Publisher · View at Google Scholar
  31. Y. S. Dong, J. L. Wang, D. Y. Feng et al., “Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage,” International Journal of Medical Sciences, vol. 11, no. 3, pp. 228–290, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. R. C. Park, J. Blom, P. J. Disaia, L. D. Lagasse, and J. A. Blessing, “Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin,” Cancer, vol. 45, no. 10, pp. 2529–2542, 1980. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Krishnappa, K. Venkatarangaiah, V. S. Kumar, S. Rajanna, R. Kashi, and P. Gupta, “Antioxidant and prophylactic effects of Delonix elata L., stem bark extracts, and flavonoid isolated quercetin against carbon tetrachloride-induced hepatotoxicity in rats,” BioMed Research International, vol. 2014, Article ID 507851, 14 pages, 2014. View at Publisher · View at Google Scholar
  34. A. G. Gornall, C. J. Bardwawill, and M. M. David, “Determination of serum proteins by means of the biuret reaction,” The Journal of Biological Chemistry, vol. 177, no. 2, pp. 751–766, 1949. View at Google Scholar · View at Scopus
  35. E. R. Jaffé, “Oxidative hemolysis, or “what made the red cell break”?” The New England Journal of Medicine, vol. 286, no. 3, pp. 156–157, 1972. View at Publisher · View at Google Scholar · View at Scopus
  36. N. W. Tietz, Clinical Guide to Laboratory Tests, WB Saunders, Philadelphia, Pa, USA, 3rd edition.
  37. N. W. Tietz, E. L. Pruden, and O. Siggaard-Andersen, “Liver function,” in Tietz Textbook of Clinical Chemistry, A. C. Burtis and E. R. Ashwood, Eds., pp. 1354–1374, WB Saunders, London, UK, 1994. View at Google Scholar
  38. S. Reltman and S. A. Frankel, “Colorimetric method for the determination of serum ALT and AST,” American Journal of Clinical Pathology, vol. 28, pp. 56–63, 1957. View at Google Scholar
  39. G. Szasz, “A kinetic photometric method for serum γ-glutamyl transpeptidase,” Clinical Chemistry, vol. 15, no. 2, pp. 124–136, 1969. View at Google Scholar · View at Scopus
  40. D. J. Jollow, J. R. Mitchell, N. Zampaglione, and J. R. Gillette, “Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3,4 bromobenzene oxide as the hepatotoxic metabolite,” Pharmacology, vol. 11, no. 3, pp. 151–169, 1974. View at Publisher · View at Google Scholar · View at Scopus
  41. S. K. Jagota and H. M. Dani, “A new colorimetric technique for the estimation of vitamin C using folin phenol reagent,” Analytical Biochemistry, vol. 127, no. 1, pp. 178–182, 1982. View at Publisher · View at Google Scholar · View at Scopus
  42. W. H. Habig, M. J. Pabst, and W. B. Jakoby, “Glutathione S transferases. The first enzymatic step in mercapturic acid formation,” Journal of Biological Chemistry, vol. 249, no. 22, pp. 7130–7139, 1974. View at Google Scholar · View at Scopus
  43. H. P. Misra and I. Fridovich, “The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase,” The Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170–3175, 1972. View at Google Scholar · View at Scopus
  44. A. K. Sinha, “Colorimetric assay of catalase,” Analytical Biochemistry, vol. 47, no. 2, pp. 389–394, 1972. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Varshney and R. K. Kale, “Effects of calmodulin antagonists on radiation-induced lipid peroxidation in microsomes,” International Journal of Radiation Biology, vol. 58, no. 5, pp. 733–743, 1990. View at Publisher · View at Google Scholar · View at Scopus
  46. W. K. Han and J. V. Bonventre, “Biologic markers for the early detection of acute kidney injury,” Current Opinion in Critical Care, vol. 10, no. 6, pp. 476–482, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. G. S. George, M. E. Wakasi, and E. Egoro, “Creatinine and urea levels as critical markers in end-stage renal failure,” Research and Review: Journal of Medical and Health Sciences, vol. 3, no. 1, pp. 41–44, 2014. View at Google Scholar
  48. M. U. Rehman, M. Tahir, F. Ali et al., “Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of Ellagic acid,” Molecular and Cellular Biochemistry, vol. 365, no. 1-2, pp. 119–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. M. U. Rehman, M. Tahir, F. Ali et al., “A case report of acute renal failure induced by melphalan in a patient with ovarian cancer,” Gan To Kagaku Ryoho, vol. 34, pp. 201–205, 1986. View at Google Scholar
  50. T. Aktoz, M. Kanter, Y. H. Uz, C. Aktaş, M. Erboğa, and I. H. Atakan, “Protective effect of quercetin against renal toxicity induced by cadmium in rats,” Balkan Medical Journal, vol. 29, no. 1, pp. 56–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. M. I. Yousef, S. A. M. Omar, M. I. El-Guendi, and L. A. Abdelmegid, “Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat,” Food and Chemical Toxicology, vol. 48, no. 11, pp. 3246–3261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Boone, D. Meyer, P. Cusick et al., “Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies,” Veterinary Clinical Pathology, vol. 34, no. 3, pp. 182–188, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Singh, T. K. Bhat, and O. M. Sharma, “Clinical biochemistry of hepatotoxicity,” Journal of Clinical Toxicology, supplement 4, pp. 1–19, 2011. View at Publisher · View at Google Scholar
  54. D. E. Amacher, “A toxicologist's guide to biomarkers of hepatic response,” Human and Experimental Toxicology, vol. 21, no. 5, pp. 253–262, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Ozer, M. Ratner, M. Shaw, W. Bailey, and S. Schomaker, “The current state of serum biomarkers of hepatotoxicity,” Toxicology, vol. 245, no. 3, pp. 194–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. S. K. Ramaiah, “A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters,” Food and Chemical Toxicology, vol. 45, no. 9, pp. 1551–1557, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. C. De David, G. Rodrigues, S. Bona et al., “Role of quercetin in preventing thioacetamide-induced liver injury in rats,” Toxicologic Pathology, vol. 39, no. 6, pp. 949–957, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. X. Y. Guo, G. F. Sun, and Y. C. Sun, “Oxidative stress from fluoride-induced hepatotoxicity in rats,” Fluoride, vol. 36, no. 1, pp. 25–29, 2003. View at Google Scholar · View at Scopus
  59. T. Yamamoto, R. Kikkawa, H. Yamada, and I. Horii, “Identification of oxidative stress-related proteins for predictive screening of hepatotoxicity using a proteomic approach,” The Journal of Toxicological Sciences, vol. 30, no. 3, pp. 213–227, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. J. M. Oh, Y. S. Jung, B. S. Jeon et al., “Evaluation of hepatotoxicity and oxidative stress in rats treated with tert-butyl hydroperoxide,” Food and Chemical Toxicology, vol. 50, no. 5, pp. 1215–1221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. G. Notas, I. E. Koutroubakis, and E. A. Kouroumalis, “Oxidants and antioxidants in liver disease,” in Antioxidants: New Research, H. V. Panglossi, Ed., pp. 2–48, Nova Science, New York, NY, USA, 2012. View at Google Scholar
  62. W. Dröge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002. View at Google Scholar · View at Scopus
  63. D. Trachootham, W. Lu, M. A. Ogasawara, N. R. Valle, and P. Huang, “Redox regulation of cell survival,” Antioxidants and Redox Signaling, vol. 10, no. 8, pp. 1343–1374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Morgenstern, J. Zhang, and K. Johansson, “Microsomal glutathione transferase 1: mechanism and functional roles,” Drug Metabolism Reviews, vol. 43, no. 2, pp. 300–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. P. J. Sherratt and J. D. Hayes, “Glutathione S-transferases,” in Enzyme Systems That Metabolise Drugs and Other Xenobiotics, C. Ioannides, Ed., pp. 219–252, John Wiley & Sons, Chichester, UK, 2002. View at Google Scholar
  66. J. Lee, N. Koo, and D. B. Min, “Reactive oxygen species, aging and antioxidative nutraceuticals,” Comprehensive Reviews in Food Science and Food Safety, vol. 3, no. 1, pp. 2–21, 2004. View at Google Scholar
  67. S. Kojo, “Vitamin C: basic metabolism and its function as an index of oxidative stress,” Current Medicinal Chemistry, vol. 11, no. 8, pp. 1041–1064, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Masella, R. di Benedetto, R. Varì, C. Filesi, and C. Giovannini, “Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes,” Journal of Nutritional Biochemistry, vol. 16, no. 10, pp. 577–586, 2005. View at Publisher · View at Google Scholar · View at Scopus